Skip to main content
. 2021 Nov 8;129(3):433–442. doi: 10.1111/1471-0528.16975

Figure 3.

Figure 3

Method of detection of pathogenic BRCA1/2 variants identified in dual‐tested patients (A) and in parallel dual‐tested patients (B).